TP53 and bone neoplasm: To demonstrate the activation of this DNA damage response pathway by Ra-223 and the ability of ATMi to inhibit this, we analyzed phosphorylation of ATM, CHK2, and p53 in PC3 bone tumors isolated from the hind limbs of BALB/c nude mice (Figure 1B).